Valuation: DBV Technologies

Market Cap 721M 842M 676M 617M 1.17B 80.26B 1.18B 7.97B 3.1B 40.5B 3.16B 3.09B 134B P/E 2026 *
-5.54x
P/E 2027 * -17x
Enterprise Value 646M 754M 605M 553M 1.04B 71.87B 1.05B 7.14B 2.78B 36.26B 2.83B 2.77B 120B EV / Sales 2026 *
252x
EV / Sales 2027 * 9.95x
Free-Float
99.85%
Yield 2026 *
-
Yield 2027 * -
1 day-0.93%
6 months-11.24%
Current year+9.23%
Current year 4.26
Extreme 4.26
4.8
1 year 3.9
Extreme 3.9
4.8
3 years 0
Extreme 0.0001
4.8
5 years 0
Extreme 0.0001
4.8
10 years 0
Extreme 0.0001
82.48
Manager TitleAgeSince
Chief Executive Officer 66 29/11/2018
Director of Finance/CFO 56 06/11/2023
Chief Operating Officer - 01/12/2023
Director TitleAgeSince
Director/Board Member 51 21/10/2015
Director/Board Member 62 21/06/2016
Director/Board Member 60 15/06/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.93%-.--% - - 842M
+3.70%+15.34%+82.76%+41.47% 372B
+0.69%+1.90%+26.68%-13.07% 70.21B
+0.32%+3.84%+50.83%+155.13% 12.33B
-0.50%+0.96%-2.77%-1.31% 8.49B
-2.31%-3.32%-14.66%-1.06% 4.89B
-1.19%-0.48%-27.57%+15.69% 4.54B
+1.34%-29.39%-24.38%+6.91% 3.04B
+0.44%-7.88%+1.65%+43.88% 2.62B
+2.75%-3.82%-14.32%-6.50% 2.05B
Average +0.41%+1.23%+8.69%+26.80% 53.32B
Weighted average by Cap. +2.87%+8.71%+68.65%+34.56%

Financials

2026 *2027 *
Net sales 2.56M 2.99M 2.4M 2.19M 4.14M 285M 4.18M 28.31M 11.02M 144M 11.22M 10.98M 476M 70.24M 81.97M 65.81M 60.12M 113M 7.81B 115M 776M 302M 3.94B 308M 301M 13.06B
Net income -174M -203M -163M -149M -281M -19.37B -284M -1.92B -749M -9.77B -763M -746M -32.36B -116M -135M -109M -99.28M -187M -12.91B -189M -1.28B -499M -6.51B -508M -497M -21.56B
Net Debt -75.46M -88.06M -70.71M -64.59M -122M -8.4B -123M -834M -325M -4.24B -331M -323M -14.03B -22.7M -26.49M -21.27M -19.43M -36.67M -2.53B -37.03M -251M -97.67M -1.27B -99.47M -97.3M -4.22B
Logo DBV Technologies
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Employees
170
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
2.438EUR
Average target price
3.637EUR
Spread / Average Target
+49.17%

Quarterly revenue - Rate of surprise